Pengaruh Radikal Bebas Terhadap Proses Inflamasi pada Penyakit Paru Obstruktif Kronis (PPOK)
Downloads
Objectives: explanation of inflammatory processes in the airways in patients with PPOK due to an increase in free radicals.
Discusion: In the human body, free radicals are metabolic products from normal cells and function as one of the body's defense systems. Free radicals can be Reactive Oxygen Species (ROS) and Reactive Nitrogen Species (RNS), both of which can be obtained from the inside (endogenous) or from outside the body (exogenous). In the pathological, exposure to cigarette smoke causes an imbalance between the amount of free radicals produced in the body so that it can lead to oxidative stress.
Conclusion: An increase in the number of free radicals will directly affect inflammatory mediators in the body. Increased free radicals will trigger the inflammatory process locally in the airways and systemically, so increasing the rate of exacerbations in COPD patients.
ABSTRAK
Latar Belakang : Penyakit PPOK ditimbulkan akibat paparan asap rokok yang terus menerus. Radikal bebas yang dibawa oleh asap rokok terhirup masuk kedalam saluran napas dapat menimbulkan eksaserbasi.
Tujuan : Menjelaskan proses eksaserbasi yang dipengaruhi oleh proses inflamasi pada penderita PPOK akibat peningkatan radikal bebas.
Ulasan : Pada tubuh manusia, radikal bebas merupakan produk hasil metabolisme dari sel normal. Pada keadaan normal, Radikal bebas berfungsi sebagai salah satu sistem pertahanan tubuh. Radikal bebas dapat berupa Reactive Oxygen Spesies (ROS) dan Reactive Nitrogen Spesies (RNS), keduanya dapat diperoleh melalui dari dalam (endogen) maupun dari luar tubuh (eksogen). Pada keadaan patologis akibat paparan asap rokok menimbulkan ketidakseimbangan antara jumlah radikal bebas yang dihasilkan dalam tubuh sehingga dapat mengakibatkan terjadinya stress oksidatif.
Kesimpulan:Peningkatan jumlah radikal bebas secara langsung akan berpengaruh pada mediator inflamasi pada tubuh. Peningkatan radikal bebas akan memicu proses inflamasi secara lokal pada saluran napas dan sistemik sehingga meningkatkan angka kejadian eksaserbasi pada penderita PPOK.
Disease Global Initiative For Chronic Obstructive Lung. Pocket Guide To Copd Diagnosis, Management, And Prevention A Guide for Health Care Professionals 2017 EDITION.
Miniño, B. A. M., Murphy, S. L. & Xu, J. National Vital Statistics Reports Deaths : Final Data for 2008. 59, (2011).
Angelis, N., Porpodis, K., Zarogoulidis, P., Spyratos, D., Kioumis, I., Papaiwannou, A., Pitsiou, G. et al. Airway inflammation in chronic obstructive pulmonary disease. J. Thorac. Dis. 6, 4–9 (2014).
Badan Penelitian dan Pengembangan Kesehatan. Riset Kesehatan Dasar (RISKESDAS) 2013. Lap. Nas. 2013 1–384 (2013). doi:1 Desember 2013
Rahman, I. Pharmacological Antioxidant Strategies As Therapeutic Interventions For COPD. Biochim Biophys Acta 1822, 714–728 (2012).
Barnes, P. J., Shapiro, S. D. & Pauwels, R. A. Chronic Obstructive Pulmonary Disease: Molecular and Cellular Mechanisms. Eur. Respir. J. 22, 672–688 (2003).
Suryadinata, R. V. et al. Pengaruh perubahan hiperplasia sel goblet selama 28 hari paparan asap rokok dengan pemberian antioksidan superoxide dismutase. Indones. J. Public Heal. 11, 60–68 (2016).
Yao, H. & Rahman, I. Current concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary disease. Toxicol. Appl. Pharmacol. 254, 72–85 (2011).
Reuter, S., Gupta, S. C., Chaturvedi, M. M. & Aggarwal, B. B. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic. Biol. Med. 49, 1603–1616 (2010).
Lobo, V., Patil, A., Phatak, A. & Chandra, N. Free radicals, antioxidants and functional foods: Impact on human health. Pharmacogn. Rev. 4, 118–126 (2010).
Phaniendra, A., Jestadi, D. B. & Periyasamy, L. Free radicals: properties, sources, targets, and their implication in various diseases. Indian J. Clin. Biochem. 30, 11–26 (2015).
Sinha, B. . Roles of Free Radicals in the Toxicity of Environmental Pollutants and Toxicants. J. Clin. Toxicol. s12, 1–3 (2013).
Kojima, C. et al. Requirement of arsenic biomethylation for oxidative DNA damage. J. Natl. Cancer Inst. 101, 1670–1681 (2009).
Obinaju, E. B. Mechanisms of arsenic toxicity and carcinogenesis. Afrincan J. Biochem. Res. 3, 232–237 (2009).
Weber, L. W. D., Boll, M. & Stampfl, A. Hepatotoxicity and Mechanism of Action of Haloalkanes: Carbon Tetrachloride as a Toxicological Model. Crit. Rev. Toxicol. 33, 105–136 (2003).
Ranguelova, K. et al. Formation of reactive sulfite-derived free radicals by the activation of human neutrophils: an ESR study. Free Radic. Biol. Med. 52, 1264–1271 (2012).
Valko, M. et al. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39, 44–84 (2007).
Suryadinata, R. V., Wirjatmadi, B. & Adriani, M. Efektivitas Penurunan Malondialdehyde dengan Kombinasi Suplemen Antioksidan Superoxide Dismutase Melon dan Gliadin Akibat Paparan Rokok. Glob. Med. Helath Commun. 5, 79–83 (2017).
Birben, E., Sahiner, U. M., Sackesen, C., Erzurum, S. & Kalayci, O. Oxidative stress and antioxidant defense. World Allergy Organ. J. 5, 9–19 (2012).
Ozougwu, J. . The Role of Reactive Oxygen Species and Antioxidants in Oxidative Stress. Int. J. Res. Pharm. Biosci. 3, 1–8 (2016).
Suissa, S., Dell'Aniello, S. & Ernst, P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax 67, 957–963 (2012).
Vestbo, J. et al. Global strategy for the diagnosis , management , and prevention of chronic obstructive pulmonary disease GOLD executive summary. Am. J. Respir. Crit. Care Med. 187, 347–365 (2013).
Cosio, M. G., Saetta, M. & Agusti, A. Immunologic Aspects of Chronic Obstructive Pulmonary Disease. N. Engl. J. Med. 360, 2445–2454 (2009).
King, P. T. et al. Lung T-cell responses to nontypeable Haemophilus influenzae in patients with chronic obstructive pulmonary disease. J. Allergy Clin. Immunol. 131, 1314–1321.e14 (2013).
Domej, W., Oettl, K. & Renner, W. Oxidative stress and free radicals in COPD--implications and relevance for treatment. Int. J. Chron. Obstruct. Pulmon. Dis. 9, 1207–1224 (2014).
Sabit, R., Thomas, P., Shale, D. J., Collins, P. & Linnane, S. J. The effects of hypoxia on markers of coagulation and systemic inflammation in patients with COPD. Chest 138, 47–51 (2010).
Pini, L., Valsecchi, A., Boni, E., Guerini, M., Tantucci, C. Acute dynamic hyperinfl ation and systemic infl ammation in stable COPD patients. in Am J Respir Crit Care Med 181 (2010).
Sharma, G., Hanania, N. A. & Shim, Y. M. The aging immune system and its relationship to the development of chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 6, 573–580 (2009).
Rabinovich, R. A. et al. Increased tumour necrosis factor-α plasma levels during moderate-intensity exercise in COPD patients. Eur. Respir. J. 21, 789–794 (2003).
Pratiwi, S. R. et al. Asupan Vitamin C dan E dengan SQ-FFQ terhadap Fungsi Paru Perokok. 14, 101–107 (2018).
Suryadinata, R. V., Lorensia, A. & Sari, R. K. Differences in Nutrition Food Intake and Body Mass Index between Smoker and Non-smoker in Adult. Indones. J. Clin. Pharm. 6, 171–180 (2017).
Fischer, B. M., Voynow, J. A. & Ghio, A. J. COPD: balancing oxidants and antioxidants. Int. J. Chron. Obstruct. Pulmon. Dis. 10, 261–276 (2015).
Chen, H., Wang, D., Bai, C., Wang, X. Proteomics-based biomarkers in chronic obstructive pulmonary disease. J Proteome Res 9, 2798–2808 (2010).
Kawamatawong, T., Apiwattanaporn, A. & Siricharoonwong, W. Serum inflammatory biomarkers and clinical outcomes of COPD exacerbation caused by different pathogens. Int. J. Chron. Obstruct. Pulmon. Dis. 12, 1625–1630 (2017).
AMERTA NUTR by Unair is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution Share-Alike (CC BY-SA).
4. The Creative Commons Attribution Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under "the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violation.
